Company: HYEX
Filing Date: 2025-04-22
Form Type: 10-K/A
Source: 0001096906-25-000553
Chunk: 82

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-22
Form: 10-K/A
Chunk 82
---
                 0% |     |             5.44% |     |              4.57% |
| Convertible Notes       |           530,860 |     |                  0 |     |           595,638 |     |            388,888 |
| Total Fair Value        |          $625,420 |     |              $0.00 |     |          $154,153 |     |           $174,234 |

The expected life of the note was based on the remaining contractual term of the instruments. The Company uses the historical volatility of its Common Stock to estimate the future volatility for its Common Stock. The expected dividend yield was based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future. The risk-free interest rate was based on rates established by the Federal Reserve Bank.

Consolidated Statement of Operations – Change in fair value on derivative

During the year ended December 31, 2023, the following transactions were recorded in the account “change in fair value on derivative”: (i) as a result of the issuance of convertible notes, the Company recorded derivative liabilities of $(); (ii) the Company viewed the convertible debt derivatives as short term and thus chose to expense the debt discounts associated with the derivative liabilities incurred during this period in the amount of $(29,167); (iii) the changes in the fair value of these derivative liabilities for the year ended December 31, 2023 resulted in a gain of $; and (iv) the Company recorded a gain on debt extinguishment of $ to account for the extinguishment of derivative liabilities associated with the settlement or the conversion of the convertible debt accounted for as a derivative liability.

During the year ended December 31, 2024, the following transactions were recorded in the account “change in fair value on derivative”: (i) the change in the fair value of these derivative liabilities for the year ended December 31, 2024 resulted in a loss of $.

The details of derivative liability transactions for the year ended December 31, 2024 and December 31, 2023 are as follows:

The change in Level 3 financial instrument fair value is as follows:

| Balance, December 31, 2022                        | $102,011 |
| Issued during the year ended December 31, 2023    |  145,067 |
| Derivative liabilities debt discount              |   29,167 |
| Change in fair value recognized